Project Partner, Sweden

P6 National Veterinary Institute and Swedish University of Agricultural Sciences, Department of Biomedicine and Veterinary Public Health, SWEPAR, Uppsala, Sweden
Represented by: Assoc. Prof. Johan Höglund

“SWEPAR” is as a designation for the combined Parasitology sections at the Swedish University of Agricultural Sciences (SLU), and at the National Veterinary Institute (SVA). SWEPAR is active in diagnostic investigation and research. The research team includes veterinarians, biologists, biotechnologists and laboratory technicians and thus the competence range of persons with expertise in the area of the epidemiology and control of parasites of ruminant livestock, to epidemiological investigations on anthelmintic resistance. Skills are also developed in molecular PCR-based techniques. At SWEPAR we have access to animal holding facilities, a research farm and a network with governmental and national industry organisation for Swedish farmers organisation. SWEPAR has participated in three European Union collaboration projects, COST 820 “Vaccines against animal coccidiosis”, COST 833 “Mange and myasis in livestock” and COST B16 “Reversal of antibiotic resistance”, as well as in two 5th framework programmes: “WORMCOPS - QLK5-CT-2001-01843” and “Diagnosis, epidemiology and prevention of Neospora caninum – associated bovine abortions, QLRT-CT-2001-01050“.

P15 SVANOVA Biotech AB, Uppsala Science Park, SE-751 83 Uppsala, Sweden
Represented by: Dr Malik Merza

SVANOVA offers a wide range of products for diagnosing infectious diseases in livestock and companion animals. Used in large-scale laboratories as well as by clinical and practical veterinarians, the majority of their products are based on the ELISA technology and marketed under the trade name SVANOVIR™. This method detects antibodies against different microorganisms, such as viruses, bacteria, parasites or mycoplasmas in various animal species. SVANOVA’s products are available for national and international health issues. Several of our tests, notably BVDV-Ab, IBR-Ab, BLV gp51-Ab and PRV-Ab have been successfully applied in eradication and control programs in countries including Sweden, Finland, Norway, Germany and Austria. SVANOVA Biotech AB was established in the beginning of 2001. The company has been founded upon the activities, which have been ongoing since 1988 within the National Veterinary Institute.
SVANOVIR™ products has since 1999 been manufactured in an ISO 9002 certified facility. In February 2003 SVANOVA Biotech AB received its certificate for the new revised quality management system ISO 9001:2000 which means that all activities at Svanova Biotech AB, such as research, development, manufacturing, marketing and sales, are now covered by this system.